… In this study, we found a low prevalence of NS5A RASs to elbasvir in HCV-GT1a-… NS5A
inhibitor. To our knowledge, this is the first Spanish nationwide survey of the prevalence of NS5A …

… A multi-centre, cross-sectional study was conducted on 632 … In this study, we observed a
low prevalence of NS5A RASs to … In conclusion, our data show that, in Spain, among patients …

… , the prevalence of NS5A resistance-associated substitutions (… among patients infected with
HCV genotype 1a in Spain, (A) … nationwide cross-sectional surveys of NS5A RASs to elbasvir …

… infected with genotype 1 (HCV-1). In this retrospective cross-sectional study, 108 HCV-1-…
In the present study, no association between the presence of RASs in any region and the …

… -based cross-sectional study accounting for more than 1 600 … Hepatitis C virus is transmitted
exclusively between humans … NIs, tend to exhibit a low prevalence of baseline RASs …

… RAS is advised before treatment with grazoprevir/elbasvir in patients … , this study analysed
the prevalence of resistance associated … This cross-sectional retrospective study included 300 …

… The presence of resistance-associated substitutions (RAS) as … A recent nationwide
cross-sectional survey enrolling 1,685 … naïve subjects in Spain 81 but it was significantly lower …

… A cross-sectional study was performed at a single large … at least one resistance associated
substitution in the NS3 region… genotype-1a infection prior to prescribing elbasvir/grazoprevir. …

… about the prevalence of resistance-associated substitutions (… cross-sectional study, 103
patients infected with HCV-1 were … that include other viral regions such as NS5A and NS5B in …

… presence of resistance-associated substitutions (RASs). This … The low frequency of baseline
NS5A RASs in Spanish … who are going to be treated with elbasvir 15 , a setting where the …